PEOPLE ON THE MOVE
UCB
Belgian biopharma UCB has made Steve Turley managing director for Britain and Ireland.
Turley has 20 years’ experience from a career at Merck & Co., Roche, Actelion and most recently, five years as MD of Lundbeck UK & Ireland.
Euronext-listed UCB reported €3.3bn ($3.5bn) in revenue last year. The company develops medicines for immune system and CNS diseases.